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Summary 
Disease characteristics.  Autism, often referred to as autistic disorder or infantile autism, is a complex 
behavioral disorder which, by definition, develops prior to age three years. Autism is defined completely on 
the basis of impairments in social interaction, impairments in communication, and repetitive and stereotypic 
behaviors. For most children, the onset of autism is gradual; however, approximately 30% have a 
"regressive" onset. Fifty to seventy percent of children with autism are defined as mentally retarded by 
nonverbal IQ testing. Seizures develop in approximately 25% of children with autism. About 25% of children 
who fit the diagnostic criteria for autism at age two or three years subsequently begin to talk and 
communicate, and by six or seven years blend to varying degrees into the regular school population. The 
remaining 75% continue to have a lifelong disability requiring intensive parental, school, and societal 
support.  
Diagnosis/testing.  The standard diagnostic criteria for autism, compiled by the American Psychiatric 
Association Manual of Psychiatric Diseases, 4th edition (DSM-IV), are the primary diagnostic reference 
used in the United States. The causes of autism can be divided into "idiopathic," which comprises the 
majority of cases, and "secondary," in which an environmental agent, chromosome abnormality, or single-
gene disorder can be identified. Approximately 5%-10% of individuals with autism can be diagnosed with 
secondary autism; the remaining 90%-95% have idiopathic autism. Approximately 30% of children with 
idiopathic autism have "complex autism," defined by the presence of dysmorphic features, microcephaly, 
and/or a structural brain malformation. About 70% of children with idiopathic autism have "essential 
autism," defined by the absence of physical abnormalities. Despite an intensive search, no genes definitely 
associated with idiopathic autism have been identified.  
Management.  Management of autism involves medical and behavioral therapies to promote 
conversational language and social interactions while mitigating repetitive, self-stimulatory behaviors, 
tantrums, aggression, and self-injurious behaviors. Therapies include predictable and routine classroom and 
home arrangements with planned transitions between activities and environments, with individualized 
intensive intervention. Visual supports, such as the Picture Exchange Communication System, are helpful in 
promoting language acquisition. The Visually Cued Instruction and Schedules program uses graphic clues to 
aid communication, organizational skills, and self management. The Social Stories intervention increases 
appropriate behavior by explaining social situations in ways understandable to the student. Medications, 
especially atypical antipsychotics, can ameliorate specific symptoms such as poor sleep or aggressive 
behavior; affected individuals may respond differently to the same medication.  
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Genetic counseling.  For individuals with secondary autism, genetic counseling is based on information 
relevant to the primary diagnosis. For idiopathic autism, the empiric aggregate risk to sibs is 4% for autism 
and an additional 4-6% risk for milder conditions, including language, social, and psychiatric disorders. For 
families with two or more affected children, the recurrence risk approaches 35%. Male sibs (brothers) of a 
proband with essential autism have a 7% risk for autism and an additional 7% risk for milder autism 
spectrum disorders. Female sibs (sisters) of a proband with essential autism have a 1% risk for autism. The 
risk for a milder autism spectrum disorder is unknown. The recurrence risk to sibs of a proband with 
complex autism is 1% for autism and an additional 2% for a milder autism spectrum disorder.  
Definition 
Clinical Manifestations 
Autism or autistic disorder is a complex behavioral disorder that, by definition, develops prior to age three. 
Infants with autism typically do not care to be held or cuddled and do not reach out to be picked up. 
Often they are "colicky" and hard to console, typically quieting more readily when left alone. They may 
avoid and fail to initiate eye contact or stare into space. Sleep disturbances and sensory issues may be 
noted in the first year. Despite early signs, children with autism usually do not come to medical attention 
until after the second year when language delays are evident. 
For most children, the onset of autism is gradual; however, approximately 30% have a "regressive" onset. 
These children begin to speak and then, often precipitously, lose language and become distant. Within a 
matter of days, the child may refuse to make eye contact and stop responding to his/her name. Deafness 
is often suspected, although hearing tests are normal. Repetitive movements may develop immediately or 
not until the child is three or four years of age. It is debated whether these children are well and then 
become damaged by some exogenous exposure or whether they are genetically determined to regress. 
Retrospective analysis of first birthday videotapes and neuropathologic studies suggest the latter 
[Osterling & Dawson 1994, Bailey et al 1998, Kemper & Bauman 1998, Casanova et al 2002]. 
Approximately 25% of children who fit the diagnostic criteria for autistic disorder at age two or three years 
subsequently begin to talk and communicate and by six or seven years blend to varying degrees into the 
regular school population. Even for this group, social impairments generally continue. For the remaining 
75%, most have some improvement with age but continue to require parent, school, and societal support. 
An excellent review of outcome studies is provided by Seltzer et al (2004). Some studies indicate that 
fewer than 5% of children with autism completely recover [Nordin & Gillberg 1998]. Autistic disorder is 
defined completely on the basis of three areas of behavioral impairment. 
l Impairments in social interaction.  Impairment in social interaction separates individuals 
with autism from the people around them. Children with autism are unable to "read" other 
people, ignoring them and often strenuously avoiding eye contact. Typically, they do not 
comfort others or seek comfort and do not share interests with others, such as bringing toys 
or pictures to their parents. Rather, they use their parents as objects, and may climb on 
them to get to a desired object, pull the parent by the hand, or place the parent's hand on 
the object, as if the child were using a tool. In clinic, the child who is content to turn pages 
of a magazine or spin the wheels of a car may become agitated when a simple examination is 
attempted. At home, the child with autism usually prefers to be by himself, engaging in his 
own, often repetitive, activities. The lack of functional or spontaneous make-believe play is 
characteristic. Toys are lined up, sorted, twirled, or hurled, but are not used for imaginative 
games or imitation of day-to-day activities, such as feeding the baby or washing the dishes. 
When play emerges later, it is stylized and not spontaneous. Children with autism fail to 
develop friendships with peers and siblings. In school, they often stand and watch other 
children from a distance. Some children respond to social overtures but take little social 
initiative, while others seek interaction but have little sense of how to proceed toward normal 
friendships.  
l Impairments in communication. Most children with autism fail to develop reciprocal 
communication either by speech, gestures, or facial expressions. Characteristically, young 
children fail to use eye gaze or pointing to communicate and direct attention. Early pragmatic 
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skills are limited and are characterized by typical rates of requesting but substantially 
reduced rates of joint attention and social interaction. Deficits in pragmatic skills are present 
throughout life and affect both language and social interaction. The young child appears 
unable to grasp the concept that speech can be used to name objects, to request a toy, or 
to engage others. In contrast to the child with nonspecific mental retardation or a primary 
developmental language disorder, who usually has better receptive than expressive language, 
the child with autism has impaired receptive language. When children with autism learn to 
talk, they display stereotypic speech that may involve echolalia, pronoun reversal, and 
unusual inflections and intonations. Unlike typically developing children who begin talking 
using one-word utterances, children with autism may begin talking in "chunks" composed of 
commercials, movies, or others' speech. These chunks often convey idiosyncratic meanings 
and the child with autism has no understanding of the conventional meaning of any of the 
individual words. Pragmatic difficulties including difficulties sustaining a conversation, turn 
taking, and allowing the conversational partners to introduce their topics, usually continue 
despite improvement in expressive speech. [reviewed in Lord et al 2004].  
l Repetitive and stereotypic behaviors.  Infants may stare or rock. Toddlers may have 
motor "stereotypies" such as movements of fingers, twirling strings, flicking pages of books, 
or licking. Repetitive whole body movements may include spinning and running back and forth. 
The repetitive behaviors often have a visual component such as holding the fingers to the 
side of the face and watching them with a sideways glance. Sometimes the movements 
become more complex with an individualized sequence of patting, rubbing, or twirling. These 
stereotypies may last for hours. Though the cause of the repetitive movements is unclear, 
they seem to have a calming effect and may, especially in the older child, surface in times of 
stress. This repetitiveness is reflected in a rigid need for sameness in daily routines. Children 
with autism can develop elaborate rituals in which the order of events, the exact words, and 
the arrangement of objects must be followed. Failure of parents/caretakers to follow the 
proscribed order of events results in inconsolable outbursts.  
Other symptoms occurring in a substantial number of individuals with autistic disorder:  
l Hyper- and hyposensitivities to sound and touch.  Loud or high-pitched noises such as 
the vacuum cleaner cause great discomfort, resulting in the child holding his hands over his 
ears. The feel of certain clothes or of being touched may be unbearable; conversely, truly 
painful stimuli like a burn or laceration are ignored.  
l Odd behaviors around foods and their presentation, such as accepting a limited number of 
foods  
l Abnormal sleep patterns (60%), such as never sleeping through the night, trouble going to 
sleep, or getting up for the day at 2:00 am  
l Tantrums and/or self-injurious and aggressive behaviors brought on by a change in 
routine, an offending touch, being asked to do something they do not want to do, or no 
apparent reason  
l Impaired motor development with toe walking early in life and general clumsiness  
l Total disregard for danger, resulting in high risk of early death, commonly from drowning  
Although no known methods can reliably distinguish those children who will improve from those who will 
have lifetime disability, the following characteristic findings are used to classify affected individuals:  
l IQ scores obtained from children with autism may change over time and with intensive 
therapy; however, the cognitive level revealed in early childhood remains an important 
predictor of long-term outcome [Lord & Schopler 1989, Kobayashi et al 1992, Volkmar 1992, 
National Research Council 2001, Howlin et al 2004]. Fifty to seventy percent of autistic 
children are defined as mentally retarded by nonverbal IQ testing [reviewed by Fombonne 
2003]. Stevens et al (2000) reported that children who tested during preschool as low 
functioning (based on nonverbal IQ, receptive vocabulary, and socialization) either remained 
low functioning or dropped significantly in their level of functioning when retested at school 
age. The authors concluded that early normal or near-normal nonverbal IQ is the best 
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predictor of adequate functioning by grade school; however, in the presence of significant 
language and social delays, it is not sufficient to insure recovery. Howlin et al (2000) 
reported that childhood scores on the Peabody Picture Vocabulary Test of receptive 
vocabulary accounted for 32% of the variance in a composite rating of outcome in adulthood.  
l Seizures develop in aapproximately 25% of children with autism; more have nonspecific EEG 
changes [Tuchman & Rapin 2002]. As in the general population, seizures alone are not a 
predictor of outcome.  
l A structural brain malformation, typically identified by MRI, usually portends a poor 
outcome [Miles & Hillman 2000].  
l Significant dysmorphology, present in 25% of individuals with autism, indicates an insult in 
early development [Miles & Hillman 2000]. Using a classification system that defines 
significant dysmorphology as having more than six dysmorphic features including minor 
anomalies, measurement abnormalities, and descriptive features not present in their non-
autistic parents, Miles et al (2005) found that dysmorphology was 81% predictive of a poor 
outcome, defined as nonverbal with an IQ lower than 55 by age eight years. In addition, 
presence of significant dysmorphology was the top predictor of a poor response to early 
intensive behavioral therapy [Stoelb et al 2004].  
l Microcephaly (head circumference <2nd centile) occurs in 5% to 15% of children with 
autism [Fombonne et al 1999, Miles et al 2000, Miles et al 2005] and is highly associated with 
poor outcome.  
l Macrocephaly (head circumference greater than the 98th centile), found in approximately 
30% of children with autism, does not appear to correlate strongly with outcome [Miles et al 
2000]. Recently, Conciatori et al (2004) presented evidence that the HOXA1 G allele 
correlates with larger head circumferences, explaining approximately 5% of the variance in 
head circumference in their population. Butler et al (2005) identified PTEN mutations in three 
of 18 young boys with both autism and macrocephaly. There were no features suggestive of 
Cowden syndrome or Bannayan-Riley-Ruvalcaba syndrome (see PTEN Hamartoma Tumor 
Syndrome) except for pigmented macules on the glans penis in one boy.  
Establishing the Diagnosis 
The standard diagnostic criteria, compiled by the American Psychiatric Association Manual of Psychiatric 
Diseases, 4th edition (DSM-IV), are the primary diagnostic reference used in the United States.  
DSM-IV Diagnostic Criteria for 299.00 Autistic Disorder 
I  A total of six (or more) items from A, B, and C, with at least two from A, and one each 
from B and C: 
A  Qualitative impairment in social interaction, as manifested by at least two 
of the following: 
1  Marked impairment in the use of multiple nonverbal behaviors 
such as eye-to-eye gaze, facial expression, body postures, and 
gestures to regulate social interaction  
2  Failure to develop peer relationships appropriate to 
developmental level  
3  A lack of spontaneous seeking to share enjoyment, interests, 
or achievements with other people (e.g., by a lack of showing, 
bringing, or pointing out objects of interest)  
4  Lack of social or emotional reciprocity  
B  Qualitative impairments in communication as manifested by at least one of 
the following: 
1  Delay in, or total lack of, the development of spoken language 
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(not accompanied by an attempt to compensate through 
alternative modes of communication such as gesture or mime)  
2  In individuals with adequate speech, marked impairment in the 
ability to initiate or sustain a conversation with others  
3  Stereotyped and repetitive use of language or idiosyncratic 
language  
4  Lack of varied, spontaneous make-believe play or social 
imitative play appropriate to developmental level  
C  Restricted repetitive and stereotyped patterns of behavior, interests, and 
activities, as manifested by at least one of the following: 
1  Encompassing preoccupation with one or more stereotyped 
and restricted patterns of interest that is abnormal either in 
intensity or focus  
2  Apparently inflexible adherence to specific, nonfunctional 
routines or rituals  
3  Stereotyped and repetitive motor mannerisms (e.g., hand or 
finger flapping or twisting or complex whole-body movements)  
4  Persistent preoccupation with parts of objects  
II  Delays or abnormal functioning in at least one of the following areas, with onset prior to 
age three years: 1) social interaction, 2) language as used in social communication, or 3) 
symbolic or imaginative play  
III  The disturbance is not better accounted for by Rett syndrome or childhood 
disintegrative disorder.  
Diagnostic tools.  To diagnose autism, one must precisely enumerate the autism symptoms and their age 
of occurrence. This can be done by using a copy of the DSM-IV or a number of checklists [Filipek et al 
2000, California DDS 2002].  
The most commonly used diagnostic checklist is the CARS (Childhood Autism Rating Scale) [Schopler et al 
1986], which consists of 15 questions scored by the parent and the tester. The CARS is a reliable, well-
verified measure, which is relatively fast and easy to administer. A score of 30 to 35 indicates mild autism 
and 36 or higher moderate-to-severe autism. Other similar checklists, including the ABC (Autism Behavior 
Checklist) [Aman et al 1985] and the GARS (Gilliam Autism Rating Scale) [Gilliam 1995], are commonly used. 
The CHAT (Checklist for Autism in Toddlers) [Baron-Cohen et al 1992] is a 14-item checklist designed as a 
screening tool for primary care providers to identify at-risk toddlers at the 18-month visit. Although its 
sensitivity has been questioned [Baird et al 2000], the CHAT is recommended by the Neurology Quality 
Standards Subcommittee [Filipek et al 1999, 2000]. The M-CHAT (Modified) [Robins et al 2001] is an 
expanded American version with 23 items that parents can fill out in the waiting room;it is available in 
Spanish and English [California DDS 2002].  
School systems usually use educationally based criteria that are similar but not identical to the medical 
criteria, sometimes leading to conflicts. This is particularly true for the higher-functioning or Asperger 
syndrome students whose autism, although equally in need of consideration and remediation through the 
schools, may not meet the educational criteria for an autism diagnosis. 
The diagnosis of Asperger syndrome is problematic, with poor concordance between the various diagnostic 
instruments [Klin et al 2005]. The Autism Spectrum Screening Questionnaire (ASSQ) [Ehlers et al 1999], 
the Asperger Syndrome Diagnositic Interview (ASDI) [Gillberg et al 2001], the Australian Scale for 
Asperger's Syndrome [Garnett & Atwood 1997], and the Childhood Asperger Syndrome Test (CAST) [Scott 
et al 2002], are commonly used for children. A new video, Asperger's Diagnostic Assessment [Attwood 
2004] provides a hands-on tutorial which should be useful to the clinician. 
In North America, research criteria for autism depend primarily on the ADI-R (Autism Diagnostic Interview-
Revised) [Lord et al 1994], which is a detailed parent interview, and the somewhat shorter ADOS (Autism 
Diagnostic Observation Schedule) [Lord et al 1989]. Both scales follow the DSM-IV criteria and were 
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developed in an attempt to sort autism by its behavioral symptoms to permit identification of homogeneous 
affected populations. Although required for research studies, these scales are not widely used in clinical 
practice because of the time and expense to administer them, though the shorter ADOS is being used in 
some clinics. 
Differential Diagnosis 
Pervasive developmental disorder (PDD) is the umbrella diagnosis that encompasses autism/autistic 
disorder, Asperger syndrome, Rett syndrome, and childhood disintegrative disorder.  
l Asperger syndrome [Asperger 1944, reprinted in English in Frith 1991] is characterized by 
relatively normal language development (which includes timing, grammar, and vocabulary) but 
includes all the other DSM-IV diagnostic criteria. Individuals with Asperger syndrome are 
generally loners, are uncomfortable in groups, cannot empathize with others, do not chat, 
follow a literal interpretation of speech with no understanding of idioms or jokes, maintain a 
sameness in routine, follow strict rules, and have an encompassing preoccupation with one 
domain, such as the weather or computers. Speech may be pedantic or repetitive with odd 
intonations. IQ is usually normal. Clumsiness is common. Whether Asperger syndrome is the 
expression of the high end of the autism spectrum or is a discrete genetic entity is unclear.  
l Childhood disintegrative disorder is an extremely rare condition manifesting before age ten 
years in which children who have developed normally for at least two years deteriorate and 
lose previously acquired language, social, and play skills. The condition may resemble autism 
in clinical presentation but differs from autism in the pattern of onset, course, and outcome.  
l Pervasive developmental disorder - not otherwise specified (PDD-NOS).  Children with 
autistic symptoms who do not meet full criteria in all three diagnostic domains can be 
diagnosed with a pervasive developmental disorder - not otherwise specified (PDD-NOS). 
PDD-NOS includes children with milder symptoms in all three domains as well as those who fit 
full autism criteria in two of the three domains. Sometimes PDD-NOS is used as an initial or 
tentative diagnosis for younger children or before diagnostic evaluations are completed.  
l Broader autism phenotype may designate siblings or other family members with some 
autism symptoms [Piven & Palmer 1999, Pickles et al 2000, Geschwind et al 2001]. This 
terminology has been adopted by researchers to identify sibs who are likely to have 
mutations in putative autism genes and reflects the growing awareness that the phenotypic 
spectrum of autism is broad.  
Prevalence 
An increase in the apparent prevalence of all the pervasive developmental disorders is being reported 
worldwide. Prior to 1990, most studies estimated a general population prevalence for autism of four to five 
per 10,000 [Jorde et al 1990, Fombonne 2001]. During the 1990s, studies of preschool children in Japan, 
England, and Sweden reported prevalence rates for autism of 21 to 31 per 10,000 [Honda et al 1996, 
Arvidsson et al 1997, Baird et al 2000]. A recent CDC case-finding study in Brick Township, New Jersey 
reported prevalence at 40 per 10,000 for autism and 67 per 10,000 for all PDDs [CDC 2000]. An important 
epidemiologic study from the United Kingdom utilizing specialized visiting nurses who monitored child health 
and development at seven months, 18 to 24 months, and three years of age reported a prevalence rate of 
16.8 per 10,000 for autism and 63 per 10,000 for all PDDs in children younger than five years of age 
[Chakrabarti & Fombonne 2001]. Those rates were recently confirmed, reporting a prevalence rate of 22 
per 10,000 for autism and 59 per 10,000 for all PDDs in children younger than six years of age [Chakrabarti 
& Fombonne 2005]. 
Evidence suggests that more complete case finding together with broadening of the diagnostic criteria are 
most responsible for the apparent increased incidence of autism [Gernsbacher et al 2005]. Studies finding 
the greatest increase in the non-autism PDDs are also recording lower rates of mental retardation in these 
children. Only 30% of children with PDDs ascertained by Chakrabarti & Fombonne (2005) were mentally 
retarded compared with 70% of children in earlier studies. This suggests that many of the higher-
functioning children with milder autistic symptoms had not been counted in past epidemiologic surveys. The 
California study [MIND Institute 2002], however, contends that changes in diagnostic criteria did not 
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account for the 273% increase in autism between 1987 and 1998 recorded in children receiving care 
through the California Regional Center system, raising the question of an environmental effect. 
Causes 
The causes of autism can be divided into "idiopathic," which comprises the majority of cases, and 
"secondary," in which chromosome abnormality, single-gene disorder or environmental agent can be 
identified. Approximately 10% of individuals with autism can be diagnosed with secondary autism; the 
remaining 90-95% have idiopathic autism. 
Environmental Causes 
In utero exposures, including rubella (German measles), valproic acid, and thalidomide, are recognized 
causes of secondary autism; however, it remains unclear whether those who develop autism after such an 
exposure are also genetically predisposed. The search for new environmental causes of secondary autism 
has centered primarily on childhood immunizations given around the time that regressive-onset autism is 
recognized. Organic mercury in the preservative thimerosal, used for certain injectable vaccines, and the 
measles-mumps-rubella (MMR) vaccine, which never contained mercury, have both been under scrutiny; 
however no scientific evidence for a relationship between vaccines and autism has been identified 
[Institute of Medicine 2001, 2004; DeStefano & Thompson 2004; Gernsbacher et al 2005]. 
Heritable Causes 
Chromosomal Causes of Autism 
l Approximately 3% of individuals with autism have a maternally inherited chromosomal 
duplication in the Prader-Willi syndrome/Angelman syndrome region of 15q11-q13. Most 
commonly, this is a supernumerary isodicentric 15q chromosome detectable by routine 
cytogenetic studies; less commonly, an interstitial duplication of the region detected by 
interphase FISH analysis of the SNRPN gene. (For laboratories offering FISH testing, see 
.) These two chromosome abnormalities have only subtle effects on the physical 
phenotype, though the phenotype associated with isodicentric 15 is typically more severe 
than with an interstitial duplication [Borgatti et al 2001, Dykens et al 2004].  
l An additional 3-5% of individuals with autism have other chromosome abnormalities, including 
apparently balanced and unbalanced translocations, inversions, rings, interstitial deletions 
and duplications, and marker chromosomes [Wassink et al 2001, Reddy 2005]. Although 
cytogenetic abnormalities on almost every chromosome have been found in association with 
autism, only a few occur commonly enough to be regarded as possible indicators of putative 
autism genes. Chromosome abnormalities (in addition to 15q duplications) that have been 
reported on more than one occasion are deletions of 2q,18q, 22q13, Xp, and the sex 
chromosome aneuploidies, 47,XYY and 45,X [Gillberg 1998, Manning et al 2004].  
 
Routine chromosome analysis detects most abnormalities; however, high-resolution 
chromosome studies, subtelomere FISH studies, or chromosomal microarray analysis are 
recommended for some persons. Reddy (2005) reported that 28% of the cytogenetic 
abnormalities detected were subtle, requiring high resolution analysis. Takahashi et al (2005) 
found unbalanced chromosome abnormalies exclusively in probands with autism who had 
significant dysmorphology (13/387 - 3.4%). All reported terminal deletions of 2q and 22q have 
been associated with dysmorphology [Lukusa et al 2004, Manning et al 2004]. 
 
The yield of subtelomeric FISH studies remains controversial. Although Wolff et al (2002) 
found that one out of ten unselected individuals with autism had a subtelomeric deletion 
detected by FISH analysis, Keller et al (2003) found no terminal deletions in 49 children with 
autism. Medne et al (2003) performed both routine chromosome analysis and subtelomeric 
FISH analysis in 108 individuals with autism; 7.4% (8/108) had a chromosome abnormality, 
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only one of which required subtelomeric FISH analysis for detection. In a retrospective study 
of 29 mentally retarded individuals with submicrocopic chromosome defects, de Vries et al 
(2001) found that prenatal growth retardation and a family history of mental retardation were 
important predictors of subtelomeric abnormalities.  
 
Chromosomal microarray analysis (CMA) can identify small deletions and duplications of the 
subtelomeres, each pericentromeric region, and other chromosome regions. Some of the 
abnormalities detected by CMA have been associated with autism; thus, CMA may replace 
subtelomeric FISH as the second-tier cytogenetic study. 
l Children with Down syndrome have autism more commonly than expected. The incidence was 
at least 7% in one study [Kent et al 1999]. This finding suggests that chromosome 
abnormalities may lower the threshold for the expression of autism.  
l Fragile X syndrome.   Whereas a very small percentage of children with autism have fragile 
X syndrome, at least half of children with fragile X syndrome have autistic behaviors, 
including avoidance of eye contact, language delays, repetitive behaviors, sleep 
disturbances, tantrums, self-injurious behaviors, hyperactivity, impulsiveness, inattention, 
and sound sensitivities. Rogers et al (2001) reported that 33% of two- to four-year-old 
children with fragile X syndrome had autism. Fragile X syndrome is caused by expansion of 
the CGG trinucleotide repeat in the FMR1 gene into a full mutation (>200 CGG repeats). 
Reports of FMR1 premutations (55-200 CGG repeats) and mosaicism for FMR1 full mutations 
associated with autism spectrum disorders indicate that molecular genetic testing of FMR1 
should be performed in all children who present with autism or PDD [Goodlin-Jones et al 2004, 
Cornish et al 2005,Reddy 2005]. Further studies are needed to determine the rate of autism 
spectrum diagnoses in individuals who are premutation carriers.  
l Rett syndrome.   One of the DSM-IV-defined pervasive developmental disorders, Rett 
syndrome exhibits considerable phenotypic overlap with autism; children with both disorders 
often have a period of normal development followed by loss of language with stereotypic 
hand movements. Decreasing rate of head growth over time and hand-wringing in female 
individuals may suggest the diagnosis of Rett syndrome. Molecular genetic testing for MECP2 
mutations that cause Rett syndrome is clinically available. However, only 1% of individuals 
with the diagnosis of autism have been reported to have a MECP2 coding region mutation 
[Voure'h et al 2001, Lam et al 2000, Zapella et al 2003, Lobo-Menendez et al 2003, Carney et 
al 2003]. Nevertheless, it appears that these two disorders may be causally related based on 
reports of variants in the 3'-UTR of MECP2 in three of 24 individuals with autism [Shibayama 
et al 2004] and variable MeCP2 expression in the brains of individuals with both Rett 
syndrome and autism [Samaco et al 2004]. The latter study suggests that defects in 
pathways that regulate MeCP2 expression may be involved in autism pathogenesis  
l Tuberous sclerosis complex.   Although 25% of mentally retarded individuals with tuberous 
sclerosis complex (TSC) have autism, only 1.1% to 1.3% of individuals with autism have TSC 
[Hunt & Dennis 1987, Smalley et al 1992, Gillberg et al 1994, Baker et al 1998].  
l Mitochondrial disorders.  Although mitochondrial respiratory chain disorders have only been 
reported in autism on rare occasion, elevated plasma concentration of lactate has been 
frequently noted [reviewed by Coleman 2005]. A population-based study of 69 children with 
autism reported elevated plasma lactate concentration in 20%; five of the eleven children 
(7.2%) undergoing muscle biopsy had a confirmed respiratory chain disorder based on 
enzymatic complex activity less than 20% of normal [Oliveira et al 2005]. If this percentage 
is confirmed, it will indicate the largest etiologic subgroup of autism. Mitochondrial disorders 
are a consideration in autistic children with atypical features such as hypotonia, failure to 
thrive, and recurrent episodes of regression or flare-ups.  
l Sotos syndrome.   An autosomal dominant disorder of macrocephaly and overgrowth, Sotos 
syndrome should be considered in children with autism who also have macrocephaly.  
l Neurofibromatosis type 1 (NF1).   Although NF1 has been diagnosed in children with 
autism, it is unclear whether this is a true association or the chance simultaneous occurrence 
of two relatively common childhood disorders.  
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l Joubert syndrome.   In one study, three of 11 children with Joubert syndrome met 
diagnostic criteria for autism and one of 11 for PDD-NOS [Ozonoff et al 1999]. However, 
Takahashi & Miles (in preparation) clearly delineated the behavioral and genetic differences 
between autism and Joubert syndrome. In a report by Muhle et al (2004) of monozygotic 
twins with Joubert syndrome, the twin with the more severe cerebellar abnormality had 
autism, suggesting that some disorders may have the potential to cause the autism 
phenotype if as yet unidentified autism regions or circuits of the brain are affected.  
l Timothy syndrome.  A disorder of calcium conductivity caused by a mutation in the 
CACNA1C gene, Timothy syndrome is characterized by severe QT prolongation, syndactyly, 
cardiac defects, dysmorphic faces, developmental delays, and autistic symptoms [Splawski et 
al 2004].  
Idiopathic Autism 
Idiopathic autism, defined as autism with no identifiable cause, is used to designate an individual in whom 
secondary autism has been eliminated by physical examination and appropriate testing. For these 
individuals, it is practical to make a distinction between "essential autism" and "complex autism" [Miles et al 
2005]. It is anticipated that both essential and complex autism will be further divided as more is learned 
about specific genetic mechanisms associated with each.  
l Essential autism is defined by the absence of physical abnormalities. Approximately 70% of 
children with idiopathic autism have essential autism. Children with essential autism are more 
likely to be male, and have a higher sibling recurrence risk and greater family history of autism 
and autism-related disorders such as alcoholism and depression. As a group, the outcome is 
better for essential autism, but most children still do poorly.  
l Complex autism is defined by the presence of dysmorphic features and/or microcephaly, 
features that indicate some alteration of early morphogenesis. Approximately 20-30% of 
children with idiopathic autism have complex autism. Complex autism is associated with a 
poorer prognosis, a lower male-to-female ratio, and a lower sibling recurrence risk.  
No genes definitely associated with idiopathic autism have been identified. Although whole-genome-wide 
scans have identified consensus regions of interest (see Table 1) including 2q31-33, 3q25-27, 6q14, 7q22, 
7q32, 13q21, 15q11-13, 16p13, 17q11,17q31, and 19p13, the studies have been difficult to replicate. This 
difficulty is variously attributed to (1) heterogeneity within and between populations studied; (2) the 
hypothesis that the effect of each of the several genes working in concert to produce the autism 
phenotype is modest; and (3) as-yet-undiscovered epigenetic effects. Additional regions of interest from 
study of chromosomal rearrangements in autism include 15q11-q13 and 7q. 
Reviews of the current status of candidate genes and loci include [Bespalova & Buxbaum 2003, Wassink et 
al 2004, Veenstra-VanderWeele & Cook 2004, Muhle et al 2004, and OMIM].  
Table 1. Candidate Susceptibility Genes in Autism (Organized by Chromosomal Location) 
Gene 
Symbol
Chromosome 
Locus
Gene/Protein 
Function
References Test 
AvailabilityPro  1 Con  2
SLC25A12 2q24
Mitochondrial 
aspartate/glutamate 
carrier
Ramoz et al 2004      
C4B 6p21 Complement component Odell et al 2005      
GLO1 6p21
Zinc metalloenzyme 
scavenges 
oxoaldehydes
Junaid et al 2004   
GRIK2 6q21
Glutamate receptor 6 
involved in neural 
development
Jamain et al 
2002, Shuang et 
al 2004
  
Devlin et al 
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Research 
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HOXA1 7p15-p14.2
Homeobox gene 
involved in hindbrain 
development
Ingram et al 
2000, Conciatori 
et al 2004
2002, Li et al 
2002, 
Talebizadeh et 
al 2002, Collins 
et al 2003, 
Romano et al 
2003, Gallagher 
et al 2004
RELN 7q22.1
Signaling protein 
involved in neuron 
migration
Persico et al 
2001, McCoy et 
al 2001, Zhang et 
al 2002
Krebs et al 
2002, Devlin et 
al 2004, Li et al 
2004
WNT2 7q31
Signaling proteins 
involved in embryonic 
patterning, cell 
proliferation and cell 
determination
Wassink et al 
2001, Hutcheson 
et al 2004
McCoy et al 
2002, Li et al 
2004
FOXP2 7q31
Transcription factor 
involved in 
embryogenesis and 
neural functioning
Gong et al 2004, 
Li et al 2005
Gauthier et al 
2003, Wassink, 
Piven et al 2002
UBE2H 7q32
Ubiquitin-dependent 
proteolytic system 
enzyme
Vourc'h et al 
2003
  
EN2 7q36.2
Homeobox gene 
involved in midbrain and 
cerebellum 
development
Petit et al 1995, 
Gharani et al 
2004
Zhong et al 
2003
PTEN 10q23.31 Tumor suppressor Butler et al 2005   
HRAS 11p15.5
Oncogene GTPase 
involved in cell division, 
differentiation and 
apoptosis
Herault et al 
1995, Comings et 
al 1996
  
AVPR1A 12q14-q15
Arginine vasopressin 
receptor involved in 
social behavior
Kim, Young et al 
2002, Wassink et 
al 2004
  
UBE3A 15q11-q13
Angelman syndrome 
causative gene 
encodes ubiquitin 
protein ligase
Nurmi et al 2001, 
Jiang et al 2004
Nurmi, Dowd et 
al 2003
ATP10C 15q11.2-q12
Phospholipid 
transporter involved in 
CNS signaling 
Nurmi, Amin et al 
2003
Kim, Herzing et 
al 2002
GABRB3, 
GABRA5, 
GABRG3 
15q11.2-q12 GABA receptor subunits
Cook et al 1998; 
Martin et al 2000; 
Nurmi et al 2001; 
Buxbaum et al 
2002; Nurmi, 
Dowd et al 2003; 
Menold et al 
2001; Shao et al 
2003; McCauley 
et al 2004
Nurmi et al 
2001, Maestrini 
et al 1999, 
Salmon et al 
1999
SLC6A4 17q11.1-q12 Serotonin transporter 
Cook et al 1997, 
Klauck et al 1997, 
Yirmiya et al 
2001, Tordjman 
et al 2001, Kim, 
Persico et al 
2000, Persico et 
al 2002, 
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Based on a variety of analysis types including linkage, association, allele sharing, transmission disequilibrium, 
subset analysis using SNPs, coding polymorphisms, and specific mutations 
1. Pro = study supporting candidate gene assignment 
2. Con = study not supporting candidate gene assignment 
Multifactorial Inheritance 
The heritability estimate of autistic disorder, calculated from recurrence risk data and monozygotic 
(MZ):dizygotic (DZ) twin concordance data, is more than 90%. Many have considered idiopathic autism to 
be a "multifactorial" disorder based on: (1) this high heritability, (2) the failure to identify major autism 
genes, (3) the 4:1 male-to-female sex ratio, and (4) sibling recurrence risk of approximately 4% [Ritvo et 
al 1989, Bolton et al 1994].  
The multifactorial threshold model predicts that the more frequently affected sex (male) has a lower 
recurrence risk than the less frequently affected sex (female) and that the less often affected sex 
(female) is more severely affected. Recent studies indicate that autism does not follow this model: (1) Sibs 
of male and female probands with idiopathic autism have the same risk of developing autism [Jones et al 
1996, Miles et al 2004], (2) the proportion of relatives with a mild subclinical autism phenotype is not 
increased when the proband is female [Pickles et al 2000]; (3) when analyses are limited to probands with 
essential autism, females have less severe autistic symptoms than males, particularly in categories of 
social interactions, pretend play, repetitive activities, and preoccupation with parts of objects [Miles et al 
2004].  
The presence of evidence that does not support the multifactorial threshold model does not eliminate the 
possibility that many genes are involved in autism, but rather suggests that the overriding impediment to 
understanding the inheritance of autism is genetic heterogeneity. 
Evaluation Strategy 
In addition to behavioral diagnostic testing, all individuals with autism should have a complete medical 
Cox et al 2002, 
Conroy et al 
2004, Mulder et al 
2005
McCauley et al 
2004
NF1 17q11.2 Ras protein regulation
Mbarek et al 
1999, Marui et al 
2004
Plank et al 2001
HOXB1 17q21-q22
Homeobox gene 
involved in hindbrain 
development
Ingram et al 2000
Li et al 2002, 
Romano et al 
2003, Gallagher 
et al 2004
APOE2 19q13.2
Lipoprotein receptor 
involved in neuronal 
migration and lipid 
transport
Persico et al 2004   
ADA 20q13.12
Purine metabolism and 
immune response
Young et al 1999, 
Kim, Young et al 
2002
  
NLGN3 Xq28 ?13
Neural synapse 
formation
Jamain et al 2003   
Clinical 
NLGN4X Xp22.33
Neural synapse 
formation
Jamain et al 
2003, Laumonnier 
et al 2004
Talebizadeh et 
al 2004, 
Gauthier et al 
2005, Vincent et 
al 2004
ARX Xp22.13 Homeobox gene
Stromme et al 
2002, Turner et al 
2002
  
Research 
only
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evaluation designed both to elucidate diagnostic possibilities and to identify medical issues that affect 
development and behavior of nonverbal children. This basic evaluation should be expanded if history and 
physical examination raise concerns about metabolic, medical, or neurologic conditions. 
Family history.  A three-generation pedigree should be obtained with attention to behavioral diagnoses. 
Relatives with behaviors that are possible manifestations of autism may be examined directly or their 
records reviewed. Language, social, and psychiatric disorders, including alcoholism, occur more often in 
relatives, including sibs, of clearly autistic probands, particularly those with essential autism [Fombonne et 
al 1997, Bolton et al 1998, Piven & Palmer 1999, Pickles et al 2000, Miles et al 2003].  
Clinical examination.  Physical examination should include the following:  
l Measurement of height, weight, and occipito-frontal circumference (OFC) to look for 
evidence of (1) microcephaly and growth retardation which suggest various chromosome 
disorders and monogenic syndromes; or (2) macrocephaly associated with Sotos syndrome.  
l A complete dysmorphology examination  
l An examination of the skin (including Woods lamp examination) evidence of tuberous sclerosis 
complex and neurofibromatosis type 1.  
Testing.  At the time of initial evaluation, the following are appropriate:  
l High-resolution chromosome analysis; consideration of chromosomal microarray analysis or 
targeted FISH studies if the individual has complex autism or a family history suggestive of a 
chromosome disorder  
l Metabolic testing. (1) The utility of a metabolic evaluation, including quantitative plasma 
amino acids; urine organic acids; plasma concentration of lactate, pyruvate, creatine kinase; 
serum concentration of uric acid; and CBC is of limited benefit for the majority of patients. 
(2) Further studies are needed to determine the prevalence of mitochondrial respiratory chain 
disorders in autism, especially those with recurrent setbacks, hypotonia, and failure to thrive.  
l Electroencephalogram, especially if there is a history of regression  
l MRI. The brain MRI helps in the classification of essential and complex autism in individuals 
with idiopathic autism; however, its use is controversial because of the expense and need for 
sedation by an anesthesiologist.  
Molecular genetic testing  
FMR1.  At the time of initial evaluation, it is appropriate to perform molecular genetic testing for fragile X 
syndrome.  
Currently, no other molecular tests are known to diagnose significant proportions of individuals with 
idiopathic autism. The following mutations have been reported in isolated cases: 
l NLGN4.  Jamain et al (2003) identified a nonsense mutation in NLGN4 in two brothers with 
autism and Asperger syndrome, both without mental retardation. Subsequently, Laumonnier 
et al (2004) identified a two-base-pair deletion in NLGN4 in 12 affected members of a French 
family with X-linked mental retardation, some of whom were also autistic.  
l NLGN3.  Jamain et al (2003) identified a C-to-T transition in the NLGN3 gene, in two 
brothers, one with autism and the other with Asperger syndrome. The mutation was inherited 
from the mother and was absent in 200 controls.  
 
Note: Subsequent studies failed to find mutations in either NLGN3 or NLGN4 in probands with 
autism [Vincent et al 2004, Talebizadeh et al 2004, Ylisaukko-Oja et al 2005]. Although 
current evidence indicates that mutations in NLGN4 or NLGN3 represent rare singe-gene 
causes of autism, their analysis could be considered for families with autism with evidence of 
X-linked inheritance. 
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l PTEN.  In a study of 18 individuals with autism spectrum disorders and macrocephaly (HC = 
+2.5 to +8 SD), Butler et al (2005) identified three with mutations in the coding region of 
PTEN. Two had no features of Cowden syndrome or Bannayan-Riley-Ruvalcaba syndrome (see 
PTEN Tumor Hamartoma Syndrome); one boy had pigmented macules on the glans penis. 
PTEN sequencing is clinically available and may be considered in an autistic individual with 
significant macrocephaly.  
Genetic Counseling 
Genetic counseling is the process of providing individuals and families with information on the nature, 
inheritance, and implications of genetic disorders to help them make informed medical and personal 
decisions. The following section deals with genetic risk assessment and the use of family history and 
genetic testing to clarify genetic status for family members. This section is not meant to address all 
personal, cultural, or ethical issues that individuals may face or to substitute for consultation with a 
genetics professional. To find a genetics or prenatal diagnosis clinic, see the GeneTests Clinic Directory. 
Secondary autism.  Five to ten percent of individuals with autism have a single-gene or chromosomal 
disorder as the underlying etiology. Genetic counseling for these families is based on information relevant to 
the primary diagnosis. Supernumerary isodicentric 15q chromosomes are de novo occurrences. Duplication 
of proximal 15q may result from segregation of a parental chromosome translocation or a maternally derived 
interstitial 15q duplication.  
Mode of Inheritance 
The mode of inheritance for idiopathic autism is unknown. 
Risk to Family Members ─ Idiopathic Autism 
Parents of a proband.  No data are available on the risk to parents of a proband of having idiopathic 
autism; however, parents are more likely to exhibit mild autistic phenotypes, such as social awkwardness, 
and a variety of psychiatric disorders including alcoholism, depression, obsessive-compulsive disorder, and 
panic and anxiety disorders [DeLong & Dwyer 1988, Smalley et al 1995, Piven & Palmer 1999, Miles et al 
2003]. Cederlund & Gillberg (2004) reported that 70% of probands with idiopathic autism studied had a 
first- or second-degree relative with autistic symptoms, and that 15% had fathers with Asperger 
syndrome.  
Sibs of a proband  
l The empiric aggregate risk to sibs of individuals with idiopathic autism is 4% for autism and an 
additional 4-6% risk for milder symptoms, including language, social, and psychiatric disorders 
[Jorde et al 1991, Bolton et al 1994, Miles et al 2005]. For families with two or more affected 
children, the recurrence risk approaches 35% [Ritvo et al 1989]. No recurrence risk data are 
available for families who have one autistic child plus another child or relative with mild 
autistic symptoms. Therefore, the amount of weight to put on mild autistic symptoms in 
siblings, parents, and other relatives when estimating recurrence risk for families is unknown.  
l Essential idiopathic autism  
¡ Male sibs (brothers) of a proband with essential autism have a 7% risk for 
autism and an additional 7% risk for milder autism spectrum symptoms.  
¡ Female sibs (sisters) of a proband with essential autism have a 1% risk for 
autism. The risk for milder autism spectrum disorder is unknown.  
l Complex idiopathic autism.  The recurrence risk to sibs of a proband with complex autism 
is 1% for autism and an additional 2% for a milder autism spectrum symptoms.  
Offspring of a proband.  No data are available.  
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Related Genetic Counseling Issues 
DNA banking.  DNA banking is the storage of DNA (typically extracted from white blood cells) for possible 
future use. Because it is likely that testing methodology and our understanding of genes, mutations, and 
diseases will improve in the future, consideration should be given to banking DNA of affected individuals. 
DNA banking is particularly relevant in situations in which molecular genetic testing is available on a 
research basis only. See DNA Banking for a list of laboratories offering this service.  
Prenatal Testing 
Prenatal testing for autism is not available. 
Management 
Treatment of Manifestations 
Optimally, an autism intervention program utilizes an experienced team of medical, behavioral, and 
educational specialists. Working with an established team is easiest for families; however, many physicians 
and families have successfully pieced together programs that work well. Early diagnosis and early intensive 
behavioral therapy are essential to an optimal outcome. The National Research Council publication 
Educating Children with Autism (2001) provides a comprehensive review and is available online. Also 
available is an evaluation of single-subject studies to determine which educational practices meet the 
criteria of "evidence-based practice" [Odom et al 2003].  
The goals of treatment are to promote functional conversational language and social interactions while 
mitigating repetitive, self-stimulatory behaviors, tantrums, aggression, and self-injurious behaviors. A 
number of alternative therapies either do not have scientific evidence of efficacy (multivitamins and 
minerals, hug therapy) or have been refuted in double blind studies (administration of secretin, facilitated 
communication, auditory training). 
Three categories of therapy exist: 
Behavioral and Educational Therapy 
The programs for which empirical evidence of efficacy exists have used structured behavioral and 
educational approaches to teach children to comprehend and use language, attend to their environment, 
imitate others, interact socially, and play appropriately with toys. Features include a functional approach 
to behavior problems and predictable and routine classroom and home arrangements with planned 
transitions between activities and environments. Validated intensive intervention with individualized one-
on-one instruction averages 25 hours per week of classroom instruction, with a minimum of 15 hours per 
week. All successful programs have a parent training component. (See Iovannone et al 2003 for a 
synthesis.) 
Intensive early-intervention programs can be classified by the extent to which teaching is contextualized. 
At one end of the spectrum are intensive, rigidly structured, decontextualized, adult-directed, one-on-one 
interventions that use the principles of Applied Behavior Analysis (ABA) [McEachin et al 1993]. Debate 
exists about the appropriateness and ultimate success of taching social and language skills in a rote 
manner. However, ABA programs that use a discrete-trial training format are supported by the most 
published data. A recent study comparing an intensive behavioral intervention program to two classroom-
based "eclectic" programs showed stronger results for the behavioral intervention [Howard et al 2005]. The 
principles of ABA have also been applied in "contemporary" ABA [Prizant et al 2000] programs in which 
instruction is embedded in home and classroom routines and the interaction is either shared or child 
directed [Hancock & Kaiser 2002]. On the other end of the spectrum are developmental social-pragmatic 
interventions, the best known of which is the Developmental, Individual-Difference, Relationship-Based 
model (DIR) [Greenspan & Wieder 2000]. The DIR model is based on the premise that adults must engage 
children with autism through the affective system. The underlying emotional processes are strengthened 
and children with autism become able to interact with people, language, and ideas in increasingly complex 
ways. However, the only published data by Greenspan & Wieder (2000) was a retrospective chart review. 
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Many children with autism require visual supports in the classroom and at home to learn to use language. 
One widely used communication intervention that capitalizes on the visual strengths of children with autism 
is the Picture Exchange Communication System (PECS) [Bondy & Frost 1994]. In the PECS system, children 
are taught to select pictures of desired objects or activities as a way of requesting access to the object 
or activity. PECS has been used successfully with children from three to six years old with cognitive skills 
ranging from severe mental retardation to normal [Schwartz et al 1998]. Although inexpensive, 
implementation initially requires two adults. Another communication intervention is the Visually Cued 
Instruction and Schedules program [Courchesne et al 1990, as cited in Dalrymple 1995], which uses 
graphic clues as an instructional or environmental prompt to aid language comprehension and 
communication, organizational skills, and improved self management. Visual Schedules provide pictures to 
help children identify the sequence of daily activities. Visually cued instruction has been used successfully 
with children with autism with a minimum age of three to six years and with IQs ranging from severe mental 
retardation to normal. Materials can be teacher-made and are inexpensive. 
Another promising intervention is Social Stories [Gray & Garand 1993]. The purpose of a Social Story is to 
increase appropriate behavior by explaining social situations in ways that are understandable to the 
student and decrease problem behavior. The assumption is that much problem behavior is caused by a lack 
of understanding of what is expected or what is going to happen; social stories build understanding, 
allowing the student to behave appropriately. Social stories are inexpensive to create and take much less 
time and expertise to implement than other interventions and have been used successfully with children 
with autsim. For a review see Kuoch & Mirenda (2003).  
Medication.  The use of medications has increased as newer medications, especially the atypical 
antipsychotics, which affect both the serotonin and dopamine systems, and serotonin re-uptake inhibitors 
(SRIs), which modulate the serotonin system, have been studied in children. In 1997, the National Institute 
of Mental Health formed the Research Units on Pediatric Psychopharmacology (RUPP) Autism Network to 
investigate the safety and efficacy of drugs for treating the behaviors associated with autism. Reports 
from that consortium have provided authoritative reviews of the pharmacotherapy of autism [McDougle et 
al 2000, Scahill et al 2001, McDougle et al 2005]. The conclusions:  
l No medications are autism specific. Medications should be selected to ameliorate a specific 
symptom such as poor sleep, aggressive or self-injurious behavior, and repetitive or 
stereotypic behaviors that interfere with learning and social interactions [Bodfish 2004, 
McDougle et al 2005].  
l A medication that alleviates one maladaptive behavior, such as aggression or hyperactivity, 
may have no effect on core autistic symptoms.  
l Marked differences exist in the efficacy and side effects of drugs in adults vs children.  
l Affected individuals may respond differently to the same medication [Gordon 2000; McDougle, 
Scahill et al 2000]. The response to a medication may reflect genetic differences between 
individuals, the waxing and waning of the behaviors over time, the progression of the 
disorder, and/or placebo effect.  
l Medication management should be integrated into a family-centered, multi-modal behavioral 
and educational program.  
Medical management.  Although most children with autism are healthy, evidence is mounting that 
medical disorders have a significant affect on behaviors, level of functioning and response to educational 
therapies. Sensory issues including a blunted pain response, inability to tell others when then are 
uncomfortable, and poor tolerance of medical evaluations can lead to suboptimal medical care. Emerging 
areas of research include gastrointestinal, feeding, sleep, metabolic, and pain disorders [Linday 2001, 
Bradley et al 2004, Polimeni et al 2005]. Anecdotal evidence of severe gastroesophogeal reflux causing 
intractable insomnia and self-injurious behaviors are compelling and indicate that physicians need to have a 
high index of suspicion, especially with unexplained behavioral exacerbations, and to provide the same level 
of medical intervention as in typically developing children.  
Targeted Therapies 
Sensory integration (SI) is the organization and processing of sensory information for specific functional 
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use. Proponents of sensory integration therapy view the aberrant behavior of children with autism as an 
attempt to establish an internal state of equilibrium. Scientific theory exists for this view, but little empiric 
data support its use. Nevertheless, caregivers at home and in the classroom report decreased 
hyperactivity, inattention, and self-stimulation following SI therapy. Although the program should be 
designed by an occupational therapist with training in sensory integration, many of the techniques, 
including brushing, use of weighted vests, swinging, and jumping are easily adapted to home and school 
use. 
Social skills interventions are designed to teach young children to engage in age-appropriate social 
interactions with their typically developing peers. Results vary [Goldstein & Cisar 1992, Goldstein et al 
1992, Sainato et al 1992, Shearer et al 1996, Zanolli et al 1996]. Classroom-based programs show greater 
generalization of improved behaviors than non-classroom-based programs. Strategies are being developed 
and tested to increase generalization and to limit the amount of teacher prompting needed to sustain the 
social interactions. 
Alternative Therapies  
A number of alternative therapies either do not have scientific evidence of efficacy (e.g., multivitamins and 
minerals, heavy metal chelation, casein free/gluten free diets) or scientific evidence in double blind studies 
has refuted efficacy (e.g., secretin, facilitated communication, auditory training).  
Resources 
See Consumer Resources for disease-specific and/or umbrella support organizations for this disorder. 
These organizations have been established for individuals and families to provide information, support, and 
contact with other affected individuals. GeneTests provides information about selected organizations and 
resources for the benefit of the reader; GeneTests is not responsible for information provided by other 
organizations.—ED. 
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